Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane in Patients With Breast Cancer

NCT03930680 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT03930680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03930680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane in Patients With Breast Cancer
Lead sponsor
University of Arkansas
Phase
Phase 1
Overall status
Completed
Start date
September 14, 2021
Completion date
June 11, 2025
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

degradation of top2b and top2a in human by dexrazoxane, effects of dexrazoxane on healthy human, time course and degradation of top2b in human by dexrazoxane